Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
<17
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.0185
EC/CAS
247-761-7/26530-20-1
Name of the chemical
2-Octyl-2H-isothiazol-3-one
Concentration
<0.0075
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.0007
General Information
Version
2.0
Revision date
2021-11-02
Product name
ZR omnibind
Emergency telephone
+32 70 245 245, +31 30 274 88 88, +353 (0)1 809 2166, +353 (0)1 809 2566, +302106479250, +302106479450
Icons in SDS
Company Information
company name
OMNICOL N.V
e-mail address of the competent person responsible for the Safety Data Sheet
info@omnicol.eu
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
Precautionary statements
P102 - Keep out of reach of children.
Supplemental label elements
EUH208 - Contains reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl- 2H-isothiazol-3-one (3:1)(55965-84-9), 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin- 3-one(2634-33-5), octhilinone (ISO); 2-octyl-2H-isothiazol-3-one(26530-20-1). May produce an allergic reaction.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Quartz (14808-60-7)
PBT Substances
not relevant – no registration required
vPvB Substances
not relevant – no registration required The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
